{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:16:18Z","timestamp":1773324978870,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Medicine Supplements"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.amjmed.2004.07.020","type":"journal-article","created":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T11:56:47Z","timestamp":1096027007000},"page":"14-22","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["Therapeutic choices in reflux disease: Defining the criteria for selecting a proton pump inhibitor"],"prefix":"10.1016","volume":"117","author":[{"given":"James W.","family":"Freston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2004.07.020_BIB1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1023\/A:1005468332122","article-title":"Upper gastrointestinal symptoms in North America","volume":"45","author":"Frank","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/BF01071906","article-title":"Symptomatic gastroesophageal reflux","volume":"21","author":"Nebel","year":"1976","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB3","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States","volume":"122","author":"Sandler","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0002-9343(97)00308-2","article-title":"Costs of acid-related disorders to a health maintenance organization","volume":"103","author":"Levin","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0016-5085(89)80065-4","article-title":"Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease","volume":"96","author":"Smith","year":"1989","journal-title":"Gastroenterology"},{"issue":"suppl","key":"10.1016\/j.amjmed.2004.07.020_BIB6","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/0002-9343(92)80051-Z","article-title":"Mechanisms of esophageal pain","volume":"92","author":"Lynn","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1053\/gast.1996.v111.pm8898633","article-title":"Dilated intercellular spaces","volume":"111","author":"Tobey","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB8","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/0016-5085(95)90135-3","article-title":"Symptom perception in gastroesophageal reflux disease is dependent on spatiotemporal reflux characteristics","volume":"108","author":"Weusten","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB9","first-page":"11","article-title":"The relationship between stress and symptoms of gastroesophageal reflux","volume":"88","author":"Bradley","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB10","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/j.1572-0241.2001.03863.x","article-title":"The role of acid and duodenal gastroesophageal reflux in symptomatic GERD","volume":"96","author":"Koek","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB11","series-title":"Gastric acid secretion. In: Acid-Related Diseases: Biology and Treatment","author":"Modlin","year":"1998"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB12","first-page":"649","article-title":"Progress with proton pump inhibition","volume":"65","author":"Bell","year":"1992","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB13","doi-asserted-by":"crossref","unstructured":"Gold BD. Gastroesophageal Reflux Disease: Could intervention in childhood reduce the risk of later complications? Am J Med. 2004;117(suppl 5A):23S\u201329S","DOI":"10.1016\/j.amjmed.2004.07.014"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB14","doi-asserted-by":"crossref","unstructured":"Sherman PM. Appropriate strategies for testing and treating Helicobacter pylori in children: when and how? Am J Med. 2004;117(suppl 5A):30S\u201335S","DOI":"10.1016\/j.amjmed.2004.07.015"},{"issue":"suppl 234","key":"10.1016\/j.amjmed.2004.07.020_BIB15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/003655201753265389","article-title":"Relative efficacies of gastric proton-pump inhibitors on a milligram basis","volume":"36","author":"Kromer","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1086-5802(16)31036-1","article-title":"Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related disease","volume":"40","author":"Welage","year":"2000","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB17","doi-asserted-by":"crossref","first-page":"74S","DOI":"10.1592\/phco.23.13.74S.31929","article-title":"Pharmacologic properties of proton pump inhibitors","volume":"23","author":"Welage","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00265957","article-title":"Pharmacokinetics of lansoprazole in patient with renal or liver disease of varying severity","volume":"45","author":"Delhotal-Landes","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB19","doi-asserted-by":"crossref","unstructured":"Bell NJV, Hunt RH. Time to maximum effect of lansoprazole on gastric pH in normal, male volunteers. Aliment Pharmacol Ther. 1996;10:897\u2013904","DOI":"10.1046\/j.1365-2036.1996.103242000.x"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2165\/00003088-199120010-00003","article-title":"Clinical pharmacology of omeprazole","volume":"20","author":"Howden","year":"1991","journal-title":"Clin Pharmacokinetics"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2125.1990.tb03679.x","article-title":"Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects","volume":"29","author":"Andersson","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB22","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1365-2036.2001.01087.x","article-title":"Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole","volume":"15","author":"Andersson","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB23","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s002280000206","article-title":"Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects","volume":"56","author":"Hassan-Alin","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2125.1991.tb05506.x","article-title":"Oral bioavailability of omeprazole before and after chronic therapy in patients with duodenal ulcer","volume":"31","author":"Ching","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00228-002-0502-1","article-title":"The effect of the area under the plasma concentration time vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH","volume":"58","author":"Junghard","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0009-9236(99)70075-5","article-title":"CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans","volume":"65","author":"Furata","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB27","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(00)70004-7","article-title":"Acid suppression","volume":"118","author":"Wolfe","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0016-5085(85)80133-5","article-title":"Omeprazole","volume":"88","author":"Prichard","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB29","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/j.1572-0241.2000.02556.x","article-title":"Lansoprazole achieves faster control of intragastric acidity than rabeprazole within the first 5 hours of administration","volume":"95","author":"Tolman","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2036.2002.01168.x","article-title":"Acid suppression in healthy subjects following lansoprazole or pantoprazole","volume":"16","author":"Huang","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2036.2002.01138.x","article-title":"Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease","volume":"16","author":"Frazzoni","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2036.2003.01405.x","article-title":"Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease","volume":"17","author":"Frazzoni","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1046\/j.1365-2036.2000.00813.x","article-title":"Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease","volume":"14","author":"Lind","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB34","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1023\/A:1015009300955","article-title":"Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease","volume":"47","author":"Rohss","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB35","first-page":"P513","article-title":"Are there any differences in symptom relief and healing esophagitis between proton pump inhibitors","volume":"45","author":"Huang","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB36","doi-asserted-by":"crossref","first-page":"A-233","DOI":"10.1016\/S0016-5085(03)81168-X","article-title":"Is a PPI a PPI","volume":"124","author":"Orebaugh","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB37","doi-asserted-by":"crossref","first-page":"A-226","DOI":"10.1016\/S0016-5085(03)81134-4","article-title":"Rational for switching proton pump inhibitor (PPI) therapy","volume":"124","author":"Katz","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB38","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1111\/j.1572-0241.2001.05263.x","article-title":"Comparing lansoprazole and omeprazole in onset of heartburn relief","volume":"96","author":"Richter","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1572-0241.2002.05532.x","article-title":"Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis","volume":"97","author":"Castell","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00044011-200323020-00001","article-title":"Lansoprazole and esomeprazole in symptomatic GERD","volume":"23","author":"Chey","year":"2003","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00044011-200222020-00004","article-title":"Evidence for therapeutic equivalence of lansoprazole 30 mg and esomeprazole 40 mg in the treatment of erosive esophagitis","volume":"22","author":"Howden","year":"2002","journal-title":"Clin Drug Invest"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2004.07.020_BIB42","first-page":"A201","article-title":"Onset and duration of pain relief in gastro-esophageal reflux disease (GERD)","volume":"122","author":"Dohmen","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archinte.161.1.45","article-title":"The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life","volume":"161","author":"Farup","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB44","unstructured":"Gallup Organization. A Gallup Organization National Survey: Understanding Heartburn in America. Princeton, NJ: The Gallup Organization, May, 2000"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB45","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1440-1746.2002.02839.x","article-title":"Gastro-oesophageal reflux disease in adults","volume":"17","author":"Katelaris","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB46","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0889-8553(05)70093-5","article-title":"Medical therapy","volume":"28","author":"Hatlebakk","year":"1999","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB47","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0889-8553(05)70095-9","article-title":"Peptic strictures of the esophagus","volume":"28","author":"Richter","year":"1999","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB48","doi-asserted-by":"crossref","first-page":"A154","DOI":"10.1016\/S0016-5085(98)80627-6","article-title":"Meta-analysis of comparative trials for healing erosive esophagitis with proton pump inhibitors and H2-receptor antagonists","volume":"114","author":"Huang","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1365-2036.2003.01756.x","article-title":"Systematic review","volume":"18","author":"Vakil","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB50","doi-asserted-by":"crossref","first-page":"A539","DOI":"10.1016\/S0016-5085(03)82725-7","article-title":"The effect of over the counter ranitidine (75 mg) on nighttime heartburn in patients with erosive esophagitis on daily proton pump inhibitor maintenance therapy","volume":"124","author":"Guda","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB51","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2036.2003.01455.x","article-title":"Comparative pharmacokinetics and safety of lansoprazole oral capsules and orally disintegrating tablets in healthy subjects","volume":"17","author":"Freston","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-200001000-00006","article-title":"Vitamin B12 levels during prolonged treat-ment with proton pump inhibitors","volume":"30","author":"Howden","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB53","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1345\/aph.1C037","article-title":"Ambulatory care increased vitamin B12 requirement associated with chronic acid suppression therapy","volume":"37","author":"Force","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjmed.2004.07.020_BIB54","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1023\/A:1020540916482","article-title":"Iron deficiency anemia","volume":"47","author":"Khatib","year":"2002","journal-title":"Dig Dis Sci"}],"container-title":["The American Journal of Medicine Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548276604000226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548276604000226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T13:54:30Z","timestamp":1549202070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548276604000226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1548276604000226"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2004.07.020","relation":{},"ISSN":["1548-2766"],"issn-type":[{"value":"1548-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}